Maplelane Capital’s Amdocs DOX Stock Holding History

Maplelane Capital’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-169,000	Closed	-$11.2M	–	123
2018 Q3	$11.2M	Sell	169,000 -25,000	-13%	-$1.65M	0.37%	63
2018 Q2	$12.8M	Sell	194,000 -106,000	-35%	-$7.13M	0.27%	87
2018 Q1	$20M	Buy	300,000 +125,000	+71%	+$8.41M	0.51%	56
2017 Q4	$11.5M	Buy	175,000 +24,999	+17%	+$1.62M	0.25%	78
2017 Q3	$9.65M	Buy	150,001 +50,001	+50%	+$3.23M	0.19%	82
2017 Q2	$6.45M	Buy	+100,000	New	+$6.31M	0.12%	97

Other funds holding DOX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Maplelane Capital's DOX Position: Q4 2018 in Review

Maplelane Capital sold out of Amdocs (DOX) in Q4 2018, closing a stake of 169,000 shares — an estimated $11.2M sold.

Maplelane Capital first reported a position in DOX in Q2 2017 and held it in 6 quarters. The position peaked at $20M in Q1 2018. 377 funds tracked by Wall St. Rank hold DOX as of Q4 2018.

Maplelane Capital reported no remaining Amdocs position as of Q4 2018 after selling out during the quarter.
Maplelane Capital sold 169,000 Amdocs shares in Q4 2018, an estimated $11.2M.
Maplelane Capital first reported a position in Amdocs in Q2 2017 and held it in 6 quarters.
Maplelane Capital's Amdocs position peaked at $20M in Q1 2018.
377 funds tracked by Wall St. Rank held Amdocs as of Q4 2018.

Based on Maplelane Capital's 13F filing for Q4 2018, filed 14 Feb 2019.